BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22362328)

  • 1. Peripheral T-cell lymphomas: diagnosis and treatment options. Proceedings from a live roundtable, August 17, 2011, Kauai, Hawaii.
    Cheson BD; Horwitz SM; Weisenburger DD
    Clin Adv Hematol Oncol; 2011 Nov; 9(11 Suppl 26):1-14; quiz 15-6. PubMed ID: 22362328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The aggressive peripheral T-cell lymphomas: 2015.
    Armitage JO
    Am J Hematol; 2015 Jul; 90(7):665-73. PubMed ID: 26031230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral T cell and natural killer (NK) T cell lymphomas: a clinicopathological study from a single Australian centre.
    McKelvie PA; Thompson PA; Tam CS
    Histopathology; 2012 Aug; 61(2):212-23. PubMed ID: 22716228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular pathogenesis of peripheral T-cell lymphoma (1): angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma, not otherwise specified and anaplastic large cell lymphoma].
    Couronné L; Bastard C; Gaulard P; Hermine O; Bernard O
    Med Sci (Paris); 2015 Oct; 31(10):841-52. PubMed ID: 26481023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOHO State of the Art Updates and Next Questions | Challenging Cases in Rare T-Cell Lymphomas.
    Bhansali RS; Barta SK
    Clin Lymphoma Myeloma Leuk; 2023 Sep; 23(9):642-650. PubMed ID: 37302955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zebras and hen's teeth: recognition and management of rare T and NK lymphomas.
    Mehta-Shah N; Horwitz S
    Hematology Am Soc Hematol Educ Program; 2015; 2015():545-9. PubMed ID: 26637770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spectrum of lymphoblastic, nodal and extranodal T-cell lymphomas: characteristic features and diagnostic dilemmas.
    Savage NM; Johnson RC; Natkunam Y
    Hum Pathol; 2013 Apr; 44(4):451-71. PubMed ID: 22658223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive T-cell lymphomas: 2021 Updates on diagnosis, risk stratification and management.
    Zain JM; Hanona P
    Am J Hematol; 2021 Aug; 96(8):1027-1046. PubMed ID: 34111312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The aggressive peripheral T-cell lymphomas: 2017.
    Armitage JO
    Am J Hematol; 2017 Jul; 92(7):706-715. PubMed ID: 28516671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas.
    Stuver R; Epstein-Peterson ZD; Horwitz SM
    Haematologica; 2023 Dec; 108(12):3244-3260. PubMed ID: 38037801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of peripheral T/NK neoplasms.
    Greer JP
    Hematology Am Soc Hematol Educ Program; 2006; ():331-7. PubMed ID: 17124080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Peripheral T-Cell Lymphoma: Many Shades of Gray.
    Lunning MA
    Oncology (Williston Park); 2015 Aug; 29(8):545-50. PubMed ID: 26281838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapeutic advancements in peripheral T-cell lymphoma.
    Reddy NM; Evens AM
    Semin Hematol; 2014 Jan; 51(1):17-24. PubMed ID: 24468312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current management of peripheral T-cell lymphomas.
    Gooptu M; Rhoades R; Pro B
    Cancer Treat Res; 2015; 165():289-303. PubMed ID: 25655615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for aggressive T-cell lymphoma: divide and conquer.
    Pinter-Brown LC
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):154-159. PubMed ID: 33275729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathologic study of 963 cases of mature T-cell and natural killer/T-cell lymphoma with respect to 2008 WHO classification of lymphoid neoplasms].
    Liang Q; Ye ZY; Su ZL; Lin HL; Shao CK; Lin SX; Rao HL; Mei KY; Zhao T; Liu YH; Luo DL; Zhu MG; Chen SH; Lin TY
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):291-5. PubMed ID: 20654150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls.
    Jaffe ES; Nicolae A; Pittaluga S
    Mod Pathol; 2013 Jan; 26 Suppl 1(Suppl 1):S71-87. PubMed ID: 23281437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.
    Shustov A
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of peripheral T-cell lymphomas.
    O'leary H; Savage KJ
    Curr Opin Hematol; 2009 Jul; 16(4):292-8. PubMed ID: 19509496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current standard in diagnostic and therapy of peripheral T-cell lymphoma].
    Hopfinger G; Staber P
    Dtsch Med Wochenschr; 2019 Oct; 144(20):1400-1404. PubMed ID: 31594013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.